4D Molecular Therapeutics, Inc. (FDMT)

CIK 1650648 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for 4D Molecular Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 20, 202640001193125-26-426810
Oct 7, 202640001193125-26-417068
Oct 5, 20261440001958244-26-000638
Sep 28, 20268-K0001193125-26-403424
Sep 22, 202640001193125-26-398204
Sep 16, 202640001193125-26-393243
Sep 14, 20261440001958244-26-000601
Sep 3, 202640001193125-26-382245
Aug 21, 202640001193125-26-361096
Aug 19, 20261440001958244-26-000539
Aug 17, 20261440001950047-26-008269
Aug 17, 202640001193125-26-354313
Aug 13, 202610-Q0001193125-26-349173
Aug 13, 20268-K0001193125-26-349160
Aug 13, 20261440001950047-26-008088
Aug 5, 202640001193125-26-335115
Aug 4, 20261440001958244-26-000477
Aug 4, 202640001193125-26-333014
Aug 3, 20261440001958244-26-000473
Jul 20, 20268-K0001193125-26-308409
Jul 14, 202640001834021-26-000004
Jul 10, 20261440001958244-26-000446
Jul 9, 20261440001958244-26-000444
Jul 2, 202640001920738-26-000004
Jun 30, 20261440001950047-26-006669